These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3832743)

  • 1. [Composition and properties of heparin and protamine complexes formed in the plasma].
    Roszkowska-Jakimiec W
    Acta Haematol Pol; 1985; 16(1-2):65-71. PubMed ID: 3832743
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of plasma proteins in formation of obstructive protamine complexes.
    De Paulis R; Mohammad SF; Chiariello L; Morea M; Olsen DB
    J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):227-33. PubMed ID: 1863742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Degradation of protamine and protamine-heparin complexes by proteolytic enzymes of blood serum and serum euglobulin fractions].
    Roszkowska W; Worowski K; Ostrowska H
    Acta Haematol Pol; 1984; 15(1-2):43-7. PubMed ID: 6516712
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
    Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
    Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of heparin binding by polycations in the presence of serum proteins].
    Mustafaev MI; Kabanov VA
    Farmakol Toksikol; 1980; 43(4):395-9. PubMed ID: 7439374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of protamine on heparin-induced increases of lidocaine free fraction.
    Dubé LM; Ho-Ngoc A; Davies RF; Beanlands DS; Mousseau N; McGilveray IJ
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):401-15. PubMed ID: 6665299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorometric determination of heparin based on self-quenching of fluorescein-labeled protamine.
    Egawa Y; Hayashida R; Seki T; Anzai J
    Talanta; 2008 Aug; 76(4):736-41. PubMed ID: 18656650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible sensing of the anticoagulant heparin with protamine permselective membranes.
    Crespo GA; Afshar MG; Bakker E
    Angew Chem Int Ed Engl; 2012 Dec; 51(50):12575-8. PubMed ID: 23124959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refinement and feasibility testing of a manual micro-method for protamine titration.
    Newall F; Johnston L; Ignjatovic V; Summerhayes R; Monagle P
    Int J Lab Hematol; 2009 Aug; 31(4):457-61. PubMed ID: 18371057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complex compounds of heparin with blood proteins and their natural inhibitors in splenectomy in animals].
    Liapina LA; Kondashevskaia MV; Azieva LD; Soboleva GI
    Patol Fiziol Eksp Ter; 1990; (4):20-2. PubMed ID: 2080078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of authentic and artifactual effect of circulating heparin on drug protein binding.
    Dubé LM; Davies RF; Beanlands DS; Mousseau N; Beaudoin N; Chan B; Ho-Ngoc A; McGilveray IJ
    Biopharm Drug Dispos; 1989; 10(1):55-68. PubMed ID: 2923961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Method of determination of protamine titre].
    Kriazhev LN; Timofeev GA
    Lab Delo; 1978; (7):434-5. PubMed ID: 80488
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
    Chang LC; Lee HF; Chung MJ; Yang VC
    Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of heparin and protamine on coagulation.
    Glowitz RJ
    Am J Clin Pathol; 1981 Jan; 75(1):130. PubMed ID: 7457424
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protaminase activity of plasma and serum in vitro. II.- Electrophoretic study of serum albumin-protamine soluble complexes].
    Blass J; Verriest C; Vicaigne MB; Detruit H; Weiss M
    Pathol Biol (Paris); 1984 Jan; 32(1):40-4. PubMed ID: 6701006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycations as possible substitutes for protamine in heparin neutralization.
    Fabian I; Aronson M
    Thromb Res; 1980 Jan 1-15; 17(1-2):239-47. PubMed ID: 7376131
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of "in vitro" degradation of protamine in plasma by three different methods.
    Weiss M; Blass J; Detruit H; Aime L; Baudet B; Fiancette JY; Gaillard M; Vicaigne MB; Verriest C
    Thromb Res; 1986 Mar; 41(5):593-604. PubMed ID: 3961737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.